The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Mental Health Clinician
(Jun 2023)
Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
Still Daniel PharmD, BCPP,
Do Kathy PharmD,
Thompson Paul PharmD, BCPP,
Brackins Todd PharmD, BCPP,
McGrory James PhD
Affiliations
Still Daniel PharmD, BCPP
ORCiD
1 Senior Director, Medical Science, Medical Affairs, Alkermes Inc, Waltham, Massachusetts
Do Kathy PharmD
ORCiD
2 Associate Director, Medical Information, Alkermes Inc, Waltham, Massachusetts
Thompson Paul PharmD, BCPP
ORCiD
3 Senior Medical Science Liaison, Alkermes Inc, Waltham, Massachusetts
Brackins Todd PharmD, BCPP
ORCiD
4 Director, Scientific Training and Development, Medical Affairs, Alkermes Inc, Waltham, Massachusetts
McGrory James PhD
ORCiD
5 Medical Director and Product Lead, Alkermes Inc, Waltham, Massachusetts
DOI
https://doi.org/10.9740/mhc.2023.06.165
Journal volume & issue
Vol. 13, no. 3
pp. 165 – 166
Abstract
Read online
No abstracts available.
WeChat QR code
Close